Columbus Macro’s Bristol-Myers Squibb BMY Stock Holding History

Columbus Macro’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-4,741	Closed	-$331K	–	156
2023 Q1	$331K	Sell	4,741 -43	-0.9%	-$3.03K	0.12%	146
2022 Q4	$344K	Sell	4,784 -140	-3%	-$10.6K	0.13%	142
2022 Q3	$350K	Sell	4,924 -237	-5%	-$17.2K	0.14%	140
2022 Q2	$399K	Buy	5,161 +35	+0.7%	+$2.67K	0.15%	131
2022 Q1	$376K	Sell	5,126 -101	-2%	-$6.78K	0.13%	134
2021 Q4	$326K	Sell	5,227 -340	-6%	-$19.9K	0.11%	137
2021 Q3	$331K	Sell	5,567 -49	-0.9%	-$3.23K	0.11%	133
2021 Q2	$375K	Sell	5,616 -10	-0.2%	-$652	0.12%	131
2021 Q1	$357K	Sell	5,626 -844	-13%	-$52.5K	0.11%	135
2020 Q4	$404K	Sell	6,470 -1,233	-16%	-$75.8K	0.12%	119
2020 Q3	$464K	Sell	7,703 -1,130	-13%	-$68K	0.14%	109
2020 Q2	$519K	Sell	8,833 -2,524	-22%	-$151K	0.14%	89
2020 Q1	$633K	Sell	11,357 -7,072	-38%	-$432K	0.18%	97
2019 Q4	$1.18M	Buy	+18,429	New	+$1.06M	0.26%	79

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Columbus Macro's BMY Position: Q2 2023 in Review

Columbus Macro sold out of Bristol-Myers Squibb (BMY) in Q2 2023, closing a stake of 4,741 shares — an estimated $331K sold.

Columbus Macro first reported a position in BMY in Q4 2019 and held it in 14 quarters. The position peaked at $1.18M in Q4 2019. 2,480 funds tracked by Wall St. Rank hold BMY as of Q2 2023.

Columbus Macro reported no remaining Bristol-Myers Squibb position as of Q2 2023 after selling out during the quarter.
Columbus Macro sold 4,741 Bristol-Myers Squibb shares in Q2 2023, an estimated $331K.
Columbus Macro first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 14 quarters.
Columbus Macro's Bristol-Myers Squibb position peaked at $1.18M in Q4 2019.
2,480 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.

Based on Columbus Macro's 13F filing for Q2 2023, filed 21 Jul 2023.